Log In
BCIQ
Print this Print this
 

NL001

  Manage Alerts
Collapse Summary General Information
Company Beijing Northland Biotech Co. Ltd.
DescriptionRecombinant targeted fusion protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard IndicationPsoriasis
Indication DetailsTreat psoriasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today